Literature DB >> 15139486

Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection.

Rinaldo Pellicano1, Giovanni Antonio Touscoz, Antonina Smedile, Mara Berrutti, Giorgio Saracco, Alessandro Repici, Antonio Ponzetto, Mario Rizzetto.   

Abstract

Autoimmunity, a feature of chronic infection by Helicobacter pylori, is first directed against gastric cells but is also associated with extragastric diseases. The aim of the present work was to look for the influence of the infection on induction of non-organ-specific autoantibodies (NOSAs). We compared 49 patients (28 males and 21 females; age range, 36-72 years; mean, 61 +/- 4.6 years) suffering from duodenal ulcer and H. pylori infection (Group A) to 38 subjects (20 male, 18 female; age range, 40-78 years; mean, 63 +/- 3.8 years) affected by duodenal ulcer related to the assumption of nonsteroidal antiinflammatory drugs (Group B). H. pylori infection was diagnosed by histology, 13C-urea breath test, and serum IgG antibodies. Autoimmunitary pattern was demonstrated by the presence of NOSAs in serum. Antinuclear (ANA), anti-smooth muscle (SMA), and anti-liver/kidney microsomal-1 (LKM-1) antibodies were present in 5 of 49 (10.2%), 2 of 49 (4%), and 0 Group A patients, respectively. In Group B, ANA was present in 3 of 38 (7.9%), SMA in 3 of 38 (7.9%), and anti-LKM-1 in 0 patients. The difference was not statistically significant. In this population, H. pylori infection is not associated with an increased prevalence of NOSAs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139486     DOI: 10.1023/b:ddas.0000020491.78450.82

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Is autoimmunity involved in the relationship between Helicobacter pylori infection, atrophic gastritis and gastric cancer?

Authors:  R Negrini
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-12

Review 2.  Role of antigastric autoantibodies in chronic Helicobacter pylori infection.

Authors:  G Faller; T Kirchner
Journal:  Microsc Res Tech       Date:  2000-03-15       Impact factor: 2.769

3.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 4.  Helicobacter pylori infection and autoimmune processes: an emerging field of study.

Authors:  D Sorrentino; G F Ferraccioli; S De Vita; A Labombarda; M Boiocchi; E Bartoli
Journal:  Ital J Gastroenterol Hepatol       Date:  1998-10

5.  Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.

Authors:  Y Nevo; A Pestronk
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

6.  The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases.

Authors:  G Macchia; A Massone; D Burroni; A Covacci; S Censini; R Rappuoli
Journal:  Mol Microbiol       Date:  1993-08       Impact factor: 3.501

7.  Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis.

Authors:  P Zentilin; B Seriolo; P Dulbecco; E Caratto; E Iiritano; D Fasciolo; C Bilardi; C Mansi; E Testa; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

8.  Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis.

Authors:  Francesco Franceschi; Antonia R Sepulveda; Antonio Gasbarrini; Paolo Pola; Nicolò Gentiloni Silveri; Giovanni Gasbarrini; David Y Graham; Robert M Genta
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

9.  Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy.

Authors:  R Nagashima; K Maeda; F Yuda; K Kudo; M Saitoh; T Takahashi
Journal:  Virchows Arch       Date:  1997-10       Impact factor: 4.064

10.  Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.

Authors:  M Lenzi; S Bellentani; G Saccoccio; P Muratori; F Masutti; L Muratori; F Cassani; F B Bianchi; C Tiribelli
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

View more
  8 in total

Review 1.  Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Helicobacter pylori infection and idiopathic thrombocytopenic purpura.

Authors:  Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 3.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

4.  Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis?

Authors:  Paolo A Tomasi; Maria P Dore; Giuseppe Fanciulli; Franca Sanciu; Giuseppe Realdi; Giuseppe Delitala
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 5.  Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.

Authors:  Masataka Kuwana
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.

Authors:  Atsuko Asahi; Tetsuya Nishimoto; Yuka Okazaki; Hidekazu Suzuki; Tatsuhiro Masaoka; Yutaka Kawakami; Yasuo Ikeda; Masataka Kuwana
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 7.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

8.  Association between vitamin B12 level and anti-parietal cells and anti-intrinsic factor antibodies among adult Jordanian patients with Helicobacter pylori infection.

Authors:  Mahmoud H Ayesh; Khaled Jadalah; Eiman Al Awadi; Khaldoon Alawneh; Basheer Khassawneh
Journal:  Braz J Infect Dis       Date:  2013-06-06       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.